(Q35648163)

English

Mechanisms of termination of atrial fibrillation by Class I antiarrhythmic drugs: evidence from clinical, experimental, and mathematical modeling studies

scientific article published on October 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

Mechanisms of termination of atrial fibrillation by Class I antiarrhythmic drugs: evidence from clinical, experimental, and mathematical modeling studies (English)

1 reference

Europe PubMed Central

9 August 2017

atrial fibrillation

1 reference

based on heuristic

inferred from title

1

object named as

Stanley Nattel

1 reference

Europe PubMed Central

9 August 2017

author name string

James Kneller

2

1 reference

Europe PubMed Central

9 August 2017

Renqiang Zou

3

1 reference

Europe PubMed Central

9 August 2017

L Joshua Leon

4

1 reference

Europe PubMed Central

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2003

1 reference

Europe PubMed Central

9 August 2017

Journal of Cardiovascular Electrophysiology

1 reference

Europe PubMed Central

9 August 2017

14

1 reference

Europe PubMed Central

9 August 2017

10 Suppl

1 reference

Europe PubMed Central

9 August 2017

S133-9

1 reference

Europe PubMed Central

9 August 2017

A COMPUTER MODEL OF ATRIAL FIBRILLATION.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

New ideas about atrial fibrillation 50 years on.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs: direct assessment of the wavelength and its modulation by a sodium channel blocker, pilsicainide

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Widening of the excitable gap and enlargement of the core of reentry during atrial fibrillation with a pure sodium channel blocker in canine atria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic properties

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Uniqueness of pilsicainide in class Ic antiarrhythmics.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Cibenzoline transforms random re-entry into ordered re-entry in the atria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Dynamics of wavelets and their role in atrial fibrillation in the isolated sheep heart

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540.8167.90302.X

21 January 2018

Identifiers

10.1046/J.1540.8167.90302.X

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35648163&oldid=2070044560"